TIGIT is a co-inhibitory receptor mainly expressed on T cells and NK cells and has been found to be highly upregulated in tumor-infiltrating lymphocytes (TILs) in melanoma and other cancers (7, 8). This evidence concerns the gene TIGIT and neoplasm.